Bagsican, Jebril Raed .
HRN: 22-94-41 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/18/2023
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
09/18/2023
09/24/2023
TOPICAL
-
Q12
T/C Bacterial Conjunctivitis
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes